1495P Cemiplimab plus chemotherapy versus chemotherapy in non-small cell lung cancer with PD-L1 ≥1%: EMPOWER-Lung 3 results
- Resource Type
- Abstract
- Authors
- Baramidze, A.; Makharadze, T.; Gogishvili, M.; Melkadze, T.; Giorgadze, D.; Penkov, K.D.; Laktionov, K.; Nemsadze, G.; Nechaeva, M.; Rozhkova, I.; Kalinka, E.; McIntyre, D.; Kaul, M.; Quek, R.G.W.; Pouliot, J-F.; Seebach, F.; Gullo, G.; Rietschel, P.
- Source
- In Annals of Oncology October 2023 34 Supplement 2:S843-S843
- Subject
- Language
- ISSN
- 0923-7534